With the help of theT32 fellowship program, I was able to complete my PhD in Neuroscience by furthering the understanding of molecular biological pathways associated with autism and depression. My key translational project included using a novel Epstein-Barr Virus (EBV)-transformed lymphocyte model system to study serotonin’s role in various aspects of treatment and diagnosis for patients with autism. This was done in conjunction with Drs. Rasenick and Cook. Always being incredibly intrigued by translational research and drawn to being at the cutting edge of science and medicine, I worked to become a Medical Science Liaison, working in various therapeutic areas, relatively soon after graduation. Currently, I am able to provide insight and translate key data about patient therapies to academic neurologists across four states in the Midwest, where I serve as a Medical Science Liaison, Associate Director at Novartis. My work with both Multiple Sclerosis and Migraine therapies provides me an opportunity to continue to foster clinical development, educate on disease state, provide insight to various thought leaders, researchers, and clinicians, and continue to grow within Medical Affairs. In conclusion, with the help of the T32, I was able to build a solid foundation in research and establish the scientific rigor and understanding that is needed to now provide educational insights to various stakeholders who have the responsibility of keeping their patients safe and providing efficacious medicines for the numerous disorders they present with. I am forever grateful and hope future students will have the same opportunity I had, especially working under the distinguished tutelage of Dr. Mark Rasenick.